Metropolitan Life Insurance Company (MetLife)’s NewtekOne NEWT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,681
Closed -$18.5K 1365
2024
Q1
$18.5K Hold
1,681
﹤0.01% 1899
2023
Q4
$23.2K Hold
1,681
﹤0.01% 1849
2023
Q3
$24.8K Buy
1,681
+370
+28% +$6.34K ﹤0.01% 1789
2023
Q2
$20.8K Buy
+1,311
New +$17.3K ﹤0.01% 1905

Other funds holding NEWT

Metropolitan Life Insurance Company (MetLife)'s NEWT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of NewtekOne (NEWT) in Q2 2024, closing a stake of 1,681 shares — an estimated $18.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NEWT in Q2 2023 and held it in 4 quarters. The position peaked at $24.8K in Q3 2023. 100 funds tracked by Wall St. Rank hold NEWT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining NewtekOne position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,681 NewtekOne shares in Q2 2024, an estimated $18.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in NewtekOne in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s NewtekOne position peaked at $24.8K in Q3 2023.
  • 100 funds tracked by Wall St. Rank held NewtekOne as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.